DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...
Dublin, March 12, 2026 (GLOBE NEWSWIRE)-- The "Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2026" report has been added to ResearchAndMarkets.com's offering. The Co-development ...
Dublin, March 12, 2026 (GLOBE NEWSWIRE)-- The "Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026" report has been added to ResearchAndMarkets.com's offering ...
Growth investors often keep a close eye on the pharmaceutical/biotech sector because of the high risk-high reward nature of investing in young companies developing novel drugs. When economic growth ...
The handbook tackles the challenging task of making German life sciences patent law accessible to international practitioners. Xenia Boergen of Boergen Legal & Patents reviews an impressive ...
(MENAFN- GlobeNewsWire - Nasdaq) Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Preclinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026" report has been added ...
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results